Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 1/20 | 0.54 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.54 |
| ▸ | SLC18A3 | Q16572 | 6/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.43 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.39 |
| ▸ | USP5 | P45974 | 1/20 | 0.39 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL444560 | 0.79 | AKR1C3 (0.56) | AKR1C3AKR1C1SLC18A3SIGMAR1NOTUM | |
| SCHEMBL1587410 | 0.78 | AKR1C3 (0.54) | AKR1C3AKR1C1SLC18A3NOTUMNPC1 | |
| SCHEMBL5007409 | 0.72 | AKR1C3 (0.51) | AKR1C3AKR1C1NOTUMAGTR2 | |
| SCHEMBL5004071 | 0.72 | HRH3 (0.46) | AKR1C3AKR1C1SLC18A3SIGMAR1AGTR2 | |
| SCHEMBL11665023 | 0.72 | AKR1C3 (0.74) | AKR1C3AKR1C1NPC1RAB9AGRIN2B | |
| SCHEMBL717453 | 0.72 | AKR1C3 (0.74) | AKR1C3AKR1C1NPC1RAB9AGRIN2B | |
| SCHEMBL7388336 | 0.72 | AKR1C3 (0.74) | AKR1C3AKR1C1NPC1RAB9AGRIN2B | |
| SCHEMBL26144401 | 0.71 | AKR1C3 (1.00) | AKR1C3AKR1C1SLC18A3SIGMAR1NOTUM | |
| SCHEMBL1073107 | 0.71 | AKR1C3 (1.00) | AKR1C3AKR1C1SLC18A3SIGMAR1NOTUM | |
| SCHEMBL17811172 | 0.71 | AKR1C3 (1.00) | AKR1C3AKR1C1SLC18A3SIGMAR1NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080280879-A1 | SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS | PFIZER INC | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280879-A1 | SUBSTITUTED HETEROCYCLIC DERIVATIVES AND THEIR PHARMACEUTICAL USE AND COMPOSITIONS | XDH, CYP2D6, F12 | AKR1C3 1826/4885AKR1C1 2592/4885SLC18A3 3846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.